Health Policy Watch

Global health donors are considering “natural selection” among non-profit drug developers as aid declines.

The partnerships behind treatments for malaria, TB and neglected diseases face an uncertain future.

Read the full report:🔗➡️healthpolicy-watch.news/funders-float-…

✍️@stefancanderson
@DNDi @medsformalaria @TBAlliance @invectorcontrol @gatesfoundation @sanofi @Novartis @WHO @IHME_UW @MSF

The FDA has approved the first generic version of lenacapavir, a twice-yearly HIV prevention injection.

Expected to cost just $40 a year, the drug could expand access in 120 low-resource countries.

Read the full report at:🔗➡️healthpolicy-watch.news/fda-approves-f…

✍️@kerrycullinan11
@FDA @drreddys @GileadSciences @UNITAID @WitsRHI @GlobalFund @gatesfoundation

French diplomat @AmprouAnne is returning to lead @WHO pandemic negotiations at a critical moment.

Countries remain divided over how to share pathogen data and the vaccines and treatments developed from it.

🔗➡️healthpolicy-watch.news/renowned-frenc…

✍️@kerrycullinan11
@WHO @DrTedros @GlobalFund @UNITAID @UN @EU_Commission @IFPMA #PABS

Abu Dhabi wants to turn wearable data into a government-backed “biological health age” score.

❓But scientists question how accurately such tools measure ageing, while consent and data governance remain unresolved.

Read the full investigation at HPW: 🔗➡️healthpolicy-watch.news/inside-abu-dha…

✍️ @rifat_WHO2024
@DoHSocial @NUSingapore @ClevelandClinic @ouraring @WHOOP @IntDiabetesFed

Switzerland has suspended $1.5 million in funding to Médecins Sans Frontières @MSF after the aid group failed to fully disclose the scale of sexual abuse and exploitation by staff in Chad.

📰➡️healthpolicy-watch.news/swiss-suspend-…

✍️@illied
@msf_schweiz @SwissDevCoop @SwissMFA @newhumanitarian